Hering R, Hoeft A, Putensen C, Tchatcheva K, Stressig R, Gembruch U, Kohl T
Department of Anaesthesiology and Intensive Care Medicine, German Centre for Fetal Surgery and Minimally-Invasive Therapy, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
Br J Anaesth. 2009 Apr;102(4):523-7. doi: 10.1093/bja/aep016. Epub 2009 Feb 24.
The purpose of our study was to evaluate the maternal cardiopulmonary function and lung water content during percutaneous fetoscopic interventions under general maternal-fetal anaesthesia and continuous tocolytic medication.
We prospectively studied 13 women between 19 and 30 weeks of gestation undergoing percutaneous fetoscopic procedures that were performed under general maternal-fetal anaesthesia and tocolysis using indomethacin. Invasive haemodynamic monitoring using pulmonary artery catheters and the transpulmonary indicator dilution technique was applied to determine intrathoracic blood volume (ITBV), cardiac output, and extravascular lung water (EVLW). Pulmonary vascular permeability was estimated as the ratio of EVLW/ITBV. Measurements were performed during and for 24 h after the interventions.
Respective mean (SD) maternal ITBV and cardiac output were 894 (191) ml min(-1) m(-2) and 3.29 (0.51) litre(-1) min(-1) m(-2) intraoperatively, and 843 (169) ml min(-1) m(-2) and 4.47 (0.55) litre min(-1) m(-2) during the first postoperative day. EVLW was 7.9 (2.7) ml kg(-1) during the interventions and 7.7 (1.8) ml kg(-1) during the first postoperative day. The pulmonary vascular permeability index was calculated as 0.35 (0.06) during the interventions and 0.38 (0.14) for the first postoperative day. Clinically overt pulmonary oedema was not detected in any woman while pulmonary gas exchange remained normal.
In mid-gestational women undergoing percutaneous fetoscopic interventions under general maternal-fetal anaesthesia, cardiopulmonary function remained stable. However, a moderate increase in EVLW and pulmonary vascular permeability indicates an increased risk for maternal pulmonary oedema.
我们研究的目的是评估在母体 - 胎儿全身麻醉和持续使用宫缩抑制剂的情况下,经皮胎儿镜干预过程中母体的心肺功能和肺含水量。
我们前瞻性地研究了13名孕周在19至30周之间接受经皮胎儿镜手术的妇女,手术在母体 - 胎儿全身麻醉下进行,并使用吲哚美辛进行宫缩抑制。采用肺动脉导管和经肺指示剂稀释技术进行有创血流动力学监测,以确定胸腔内血容量(ITBV)、心输出量和血管外肺水(EVLW)。肺血管通透性以EVLW/ITBV的比值来估计。在干预期间及干预后24小时进行测量。
术中母体ITBV和心输出量的各自均值(标准差)分别为894(191)ml·min⁻¹·m⁻²和3.29(0.51)L·min⁻¹·m⁻²,术后第一天分别为843(169)ml·min⁻¹·m⁻²和4.47(0.55)L·min⁻¹·m⁻²。干预期间EVLW为7.9(2.7)ml·kg⁻¹,术后第一天为7.7(1.8)ml·kg⁻¹。干预期间肺血管通透性指数计算为0.35(0.06),术后第一天为0.38(0.14)。在任何女性中均未检测到临床明显的肺水肿,而肺气体交换保持正常。
在接受母体 - 胎儿全身麻醉下经皮胎儿镜干预的孕中期女性中,心肺功能保持稳定。然而,EVLW和肺血管通透性的适度增加表明母体发生肺水肿的风险增加。